For people interested in risk management, medical activity
represents a stimulating field of study and thought. On the one
hand, progress in medical knowledge and technology tends to reduce
the risks to survival that individuals would face in the absence of
appropriate diagnostic or therapeutic instruments. On the other
hand, new medical technologies simultaneously create their own
specific risks, sometimes simply because their effects are less
well-known than those of established ones. In a sense any medical
progress simultaneously generates new risks while destroying old
ones. Moreover, unlike many financial risks that can be either
divided or transferred to others (e.g. through diversification,
insurance or social security) the personal aspects of medical risks
are by essence indivisible and non-transferable. As a result, they
are in a sense more threatening than financial risks for risk
averse patients. These two facts explain and justify the growing
interest in risk economics for the fields of medical decision
making and health economics.
In Risk and Medical Decision Making, part 1 is developed inside
the expected utility (E-U) model and analyses how comorbidity risks
affect the well-known "test-treatment" thresholds. Part 2 is
devoted to a specific non E-U model with the same purpose: how
would one define a threshold in this context and how would one
value a diagnostic test? In each of these two parts both diagnostic
and therapeutic risks are considered.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!